BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18204787)

  • 1. Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer.
    Pries R; Hogrefe L; Xie L; Frenzel H; Brocks C; Ditz C; Wollenberg B
    Int J Mol Med; 2008 Feb; 21(2):209-15. PubMed ID: 18204787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck cancer triggers the internalization of TLR3 in natural killer cells.
    Xie L; Pries R; Kesselring R; Wulff S; Wollenberg B
    Int J Mol Med; 2007 Oct; 20(4):493-9. PubMed ID: 17786279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
    Chiron D; Pellat-Deceunynck C; Amiot M; Bataille R; Jego G
    J Immunol; 2009 Apr; 182(7):4471-8. PubMed ID: 19299748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells.
    Nakada E; Walley KR; Nakada T; Hu Y; von Dadelszen P; Boyd JH
    Placenta; 2009 Sep; 30(9):774-9. PubMed ID: 19631980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Established and novel NF-κB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC.
    Meyer C; Pries R; Wollenberg B
    Oral Oncol; 2011 Sep; 47(9):818-26. PubMed ID: 21745758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor interference in myeloid dendritic cells through head and neck cancer.
    Frenzel H; Hoffmann B; Brocks C; Schlenke P; Pries R; Wollenberg B
    Anticancer Res; 2006; 26(6B):4409-13. PubMed ID: 17201162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
    Allen CT; Ricker JL; Chen Z; Van Waes C
    Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages.
    Huang SH; Cao XJ; Wei W
    J Pineal Res; 2008 Aug; 45(1):93-100. PubMed ID: 18312297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma.
    Hung PS; Kao SY; Shih YH; Chiou SH; Liu CJ; Chang KW; Lin SC
    J Pathol; 2008 Feb; 214(3):368-76. PubMed ID: 18085517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
    Salaun B; Lebecque S; Matikainen S; Rimoldi D; Romero P
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4565-74. PubMed ID: 17671143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
    Liu H; Schwartz MJ; Hwang DH; Scherr DS
    BJU Int; 2008 Apr; 101(7):894-901. PubMed ID: 18241249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly(I:C).
    Liu Y; Kimura K; Yanai R; Chikama T; Nishida T
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3336-44. PubMed ID: 18660424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism.
    Paone A; Starace D; Galli R; Padula F; De Cesaris P; Filippini A; Ziparo E; Riccioli A
    Carcinogenesis; 2008 Jul; 29(7):1334-42. PubMed ID: 18566014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of apoptosis in human head and neck cancer cell lines by an active component of OK-432 through p53-independent pathway via toll-like receptor (TLR) 4 signaling].
    Tano T; Okamoto M; Oshikawa T; Ahmed SU; Sasai A; Sato M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1562-4. PubMed ID: 16315869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG
    Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down modulation of human TLR3 function by a monoclonal antibody.
    Duffy KE; Lamb RJ; San Mateo LR; Jordan JL; Canziani G; Brigham-Burke M; Korteweg J; Cunningham M; Beck HS; Carton J; Giles-Komar J; Duchala C; Sarisky RT; Mbow ML
    Cell Immunol; 2007 Aug; 248(2):103-14. PubMed ID: 18048020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.